GH Research GHRS
NASDAQ GHRS
$28.23 +0.31 (+1.11%)
As of: Sep 4, 2026 · 3:59 PM EDT

GH Research (GHRS) Long-Term Investments (2021 - 2025)

GH Research (GHRS) posted quarterly Long-Term Investments of $34.5 million for Q4 2025, up 3.47% year-over-year from $33.3 million in Q4 2024, and down 11.31% quarter-over-quarter from $38.9 million in Q3 2025.

Analysis

GH Research (GHRS) Long-Term Investments (2021 - 2025) Analysis & Trends

GH Research's Long-Term Investments history runs 5 years deep, the most recent figure standing at $34.5 million for Q4 2025.

  • In Q4 2025, Long-Term Investments rose 3.47% year-over-year to $34.5 million; the TTM figure through Dec 2025 stood at $34.5 million (up 3.47% YoY), while the FY2025 annual figure was $34.5 million, up 3.47% from the prior year.
  • Long-Term Investments for Q4 2025 stood at $34.5 million, down from $38.9 million in the prior quarter.
  • The five-year high for Long-Term Investments was $122.1 million in Q4 2021, with the low at $33.3 million in Q4 2024.
  • The 5-year median for Long-Term Investments is $54.7 million (2024), against an average of $58.8 million.
  • The sharpest annual moves came in 2024 and 2025: Long-Term Investments plunged 45.54% in 2024, then advanced 3.47% in 2025.
  • GH Research's Long-Term Investments stood at $122.1 million in 2021, then dropped by 29.78% to $85.7 million in 2022, then slipped by 28.68% to $61.1 million in 2023, then sank by 45.54% to $33.3 million in 2024, then gained by 3.47% to $34.5 million in 2025.
  • Business Quant data shows GHRS's Long-Term Investments at $34.5 million in Q4 2025, $38.9 million in Q3 2025, and $37.7 million in Q2 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 5.79 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 9.83 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -4.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 1.77 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 22.17 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 372.10 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 GH Research 1.72 Bn 1.36 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 134.24 Mn
Dec 31, 2024 126.77 Mn
Dec 31, 2023 125.87 Mn
Dec 31, 2022 123.66 Mn
Dec 31, 2021 122.08 Mn